Teams at Sana Biotechnology, Inc.

Leads an MSAT team supporting Phase I manufacturing of a stem cell-derived pancreatic islet cell therapy. Oversees technology transfer, manufacturing readiness, people-in-plant coverage, operator training, batch record review, investigations, troubleshooting, comparability studies, and process improvements at an external manufacturing partner. Authors CMC sections for IND Module 3, collaborates with Quality, Supply Chain, Research, and Process Development, and develops team talent while supporting regulated cell therapy manufacturing.

Lead FP&A activities supporting R&D, CMC, and G&A functions: own budgeting, forecasting, long-range planning, variance analysis, close support, expense recognition under US GAAP, reporting/dashboard creation, and process improvements to enable executive decision-making and spending discipline.

Lead evaluation, structuring, negotiation, and management of licensing, partnerships, co-development, platform transactions, and strategic collaborations. Coordinate cross-functional diligence (R&D, CMC, clinical, regulatory, legal, IP, finance, commercial), build valuation and financial frameworks, negotiate term sheets and definitive agreements, manage partner relationships and post-signing governance, and support executive and Board-level decision-making and strategic planning.